Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread ...
Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With ...
Doctors may soon have a new tool in the fight against one of the most aggressive and lethal forms of cancer—in the form of an 'early warning' signature of precancerous cells. This is the promise of a ...
Early clinical and preclinical results are showing that experimental mRNA and nanoparticle vaccines produced measurable immune responses against pancreatic cancer, one of the deadliest cancers, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results